5-(2-siklopropyl-1-(4-fluorophenyl) -2-oxoethyl) -4,5,6, -tetrahydrothieno[3,2-c]Piridin-2-yl-yl D' CAS 139194-50-5

Pwodwi Deskripsyon:

Non pwodwi: 5-(2-siklopropyl-1-(4-fluorophenyl) -2-oxoethyl) -4,5,6 7-tetrahydrothieno[3,2-c]piridin-2-yl D' CAS NON: 1391194-50-5

 

Sinonim:

Prasugrel Para-Fluoro Isomer;

 

Chimik & Pwopriyete fizik:

Aparans : poud blan

Assay: ≥97.0%

Dansite: 1.347g / cm3

Bouyi pwen: 497.6 ° Cat 760 mmHg

Flash Pwen: 254.7 ° C

 

Prasugrel Impurity / Entemedye.

Prasugrel tou te gen yon pefomans pi fo pase clopidogrel nan ki estab pektori angina ak sendwom korone entevansyonel korone tou, men pi fo efe a antiplatel, gen plis chans li se lakoz senyen. Kesyon an kle kounye a se ki jan yo idantifye pasyan nan risk segonde nan trombosis nan pratik klinik, ak ki jan yo idantifye moun ki gen gwo risk pou yo senyen, se konsa ke prasugrel ak clopidogrel ka itilize diferan nan de gwoup yo ki wo risk, ki ka redwi tronbosis korone epi evite gwo senyen. Sou Desanm 18, 2008, Prasugrel te resevwa premye apwobasyon entenasyonal li yo, ak Komite Ewopeyen an pou pwodwi medikal pou Itilizasyon Imen (CHMP) nan Ajans Ewopeyen an rekomande apwobasyon nan dwog la.

 

 

Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

 

Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a bay manti selman ak achte a.

Baj popilè: 5-(2-siklopropyl-1-(4-fluorophenyl) -2-oxoethyl) -4,5,6,7-tetra 3,2-c]pyridin-2-yl D' cas 139194-50-50, manifaktire, founise, faktori, achte, nan machandiz

• On: (R) -Rivaxaban CAS 865479-71-6
• Pwochen: 1-cyclopropyl-2-(2-fluorophenyl)ethane-1,2-dione CAS 1391054-37-7